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Abstract Human-based modelling and simulations are becoming ubiquitous in biomedical
science due to their ability to augment experimental and clinical investigations. Cardiac
electrophysiology is one of the most advanced areas, with cardiac modelling and simulation being
considered for virtual testing of pharmacological therapies and medical devices. Current models
present inconsistencies with experimental data, which limit further progress. In this study, we
present the design, development, calibration and independent validation of a human-based
ventricular model (ToR-ORd) for simulations of electrophysiology and excitation-contraction
coupling, from ionic to whole-organ dynamics, including the electrocardiogram. Validation based
on substantial multiscale simulations supports the credibility of the ToR-ORd model under healthy
and key disease conditions, as well as drug blockade. In addition, the process uncovers new
theoretical insights into the biophysical properties of the L-type calcium current, which are critical
for sodium and calcium dynamics. These insights enable the reformulation of L-type calcium
current, as well as replacement of the hERG current model.
Introduction
Human-based computer modelling and simulation are a fundamental asset of biomedical research.
They augment experimental and clinical research through enabling detailed mechanistic and system-
atic investigations. Owing to a large body of research across biomedicine, their credibility has
expanded beyond academia, with vigorous activity also in regulatory and industrial settings. Thus,
human in silico clinical trials are now becoming a central paradigm, for example, in the development
of medical therapies (Pappalardo et al., 2018). They exploit mature human-based modelling and
simulation technology to perform virtual testing of pharmacological therapies or devices.
Human cardiac electrophysiology is one of the most advanced areas in physiological modelling
and simulation. Current human models of cardiac electrophysiology include detailed information on
the ionic processes underlying the action potential such as the sodium, potassium and calcium ionic
currents, exchangers such as the Na/Ca exchanger and pumps such as the Na/K pump. They also
include representation of the excitation-contraction coupling system in the sarcoplasmic reticulum,
an important modulator of the calcium transient, through the calcium-induced calcium-release mech-
anisms and the SERCA pump. Several human models have been proposed for ventricular electro-
physiology, and amongst them the ORd model (O’Hara et al., 2011). Its key strengths are the
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representation of CaMKII signalling, capability to manifest arrhythmia precursors such as alternans
and early afterdepolarisation, and good response to simulated drug block and disease remodelling
(Dutta et al., 2016; Dutta et al., 2017a; Passini et al., 2016; Tomek et al., 2017). Consequently,
ORd was selected by a panel of experts as the model best suited for regulatory purposes
(Dutta et al., 2017a).
Most of the ORd model development has focused on repolarisation properties such as its
response to drug block, repolarisation abnormalities and its rate dependence. However, a more
holistic comparison of ORd-based simulations with human ventricular experimental data reveals
important inconsistencies. Firstly, the plateau of the action potential (AP) is significantly higher in the
ORd model than in experimental data used for ORd model construction (O’Hara et al., 2011;
Britton et al., 2017) and in data from additional studies using human cardiomyocytes
(Coppini et al., 2013; Jost et al., 2013). Secondly, the dynamics of accommodation of the AP dura-
tion (APD) to heart rate acceleration, which are known to be modulated by sodium dynamics, show
only limited agreement with a comparable experimental dataset (Franz et al., 1988; O’Hara et al.,
2011). Thirdly, we identify that simulations of the sodium current block has an inotropic effect in the
ORd model, increasing the amplitude of the calcium transient, in disagreement with its established
negatively inotropic effect in experimental/clinical data (encainide, flecainide, and TTX)
(Gottlieb et al., 1990; Tucker et al., 1982; Legrand et al., 1983; Bhattacharyya and Vassalle,
1982). All those properties, namely AP plateau potential, APD adaptation and response to sodium
current block, have strong dependencies on sodium and calcium dynamics. We therefore hypothe-
sise that ionic balances during repolarisation require further research. We specifically focus on an in-
depth re-evaluation of the L-type calcium current (ICaL) formulation, given its fundamental role in
determining the AP, the calcium transient and sodium homeostasis through the Na/Ca exchanger.
The second main focus is the re-assessment of the rapid delayed rectifier current (IKr), the dominant
repolarisation current in human ventricle, under conditions that reflect experimental data-driven pla-
teau potentials.
Using a development strategy based on strictly separated model calibration and validation, we
sought to design, develop, calibrate and validate a novel model of human ventricular electrophysiol-
ogy and excitation contraction coupling, the ToR-ORd model (for Tomek, Rodriguez – following
ORd). Our aim for simulations using the ToR-ORd model is to be able to reproduce all key depolar-
isation, repolarisation and calcium dynamics properties in healthy ventricular cardiomyocytes, under
drug block, and in key diseased conditions such as hyperkalemia (central to acute myocardial ische-
mia), and hypertrophic cardiomyopathy.
eLife digest Decades of intensive experimental and clinical research have revealed much about
how the human heart works. Though incomplete, this knowledge has been used to construct
computer models that represent the activity of this organ as a whole, and of its individual chambers
(the atria and ventricles), tissues and cells. Such models have been used to better understand life-
threatening irregular heartbeats; they are also beginning to be used to guide decisions about the
treatment of patients and the development of new drugs by the pharmaceutical industry.
Yet existing computer models of the electrical activity of the human heart are sometimes
inconsistent with experimental data. This problem led Tomek et al. to try to create a new model that
was consistent with established biophysical knowledge and experimental data for a wide range of
conditions including disease and drug action.
Tomek et al. designed a strategy that explicitly separated the construction and validation of a
model that could recreate the electrical activity of the ventricles in a human heart. This model was
able to integrate and explain a wide range of properties of both healthy and diseased hearts,
including their response to different drugs. The development of the model also uncovered and
resolved theoretical inconsistencies that have been present in almost all models of the heart from
the last 25 years. Tomek et al. hope that their new human heart model will enable more basic,
translational and clinical research into a range of heart diseases and accelerate the development of
new therapies.
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Materials and methods
Strategy for construction, calibration and validation of the ToR-ORd
model
Table 1 lists the properties (left column) and key references (right column) of experimental and clini-
cal datasets considered for the calibration (top) and independent validation (bottom) of the ToR-
ORd model. This represents a comprehensive list of properties, known to characterize human ven-
tricular electrophysiology under multiple stimulation rates, and also drug action and disease. The
recordings in were obtained in human ventricular preparations primarily using measurements with
microelectrode recordings, unipolar electrograms, and monophasic APs, therefore avoiding photon
scattering effects or potential dye artefacts present in optical mapping experiments. In addition, the
ToR-ORd model was calibrated to manifest depolarisation of resting membrane potential in
response to an IK1 block, based on evidence in a range of studies summarised in Dhamoon and
Jalife (2005). The calibration criteria are chosen to be fundamental properties of ionic currents,
action potential and single-cell pro-arrhythmic phenomena (described in more detail in Appendix 1-
1). The validation criteria include response to rate changes, drug action and disease, to explore the
predictive power of the model under clinically-relevant conditions.
We initially performed the evaluation of the ORd model (O’Hara et al., 2011) by conducting sim-
ulations for each of the calibration criteria in Table 1. Further details are described throughout
the Materials and methods section and Appendix 1-15.1. Simulations with the existing versions of
the ORd model failed to fulfil key criteria such as AP morphology, calcium transient duration, several
properties of the L-type calcium current, negative inotropic effect of sodium blockers, or the depo-
larising effect of IK1 block. The results are later demonstrated in Figures 2 and 3, and Methods: Cali-
bration of IK1 block and resting membrane potential. Secondly, we attempted parameter
optimisation using a multiobjective genetic algorithm (Torres et al., 2012). However, simulations
with the ORd-based models were unable to fulfil key criteria such as AP and Ca morphology, and
the effect of sodium and calcium block on calcium transient amplitude and APD, respectively.
We then proceeded to reevaluate the ionic current formulations based on experimental data and
biophysical knowledge. Key currents included ICaL and specifically its driving force and activation, as
Table 1. Criteria and human-based studies used in ToR-ORd calibration and validation.
Calibration
Action potential morphology (Britton et al., 2017; Coppini et al., 2013; Jost et al., 2013)
Calcium transient time to peak, duration, and amplitude (Coppini et al., 2013)
I-V relationship and steady-state inactivation of L-type
calcium current
(Magyar et al., 2000)
Sodium blockade is negatively inotropic (Gottlieb et al., 1990; Tucker et al., 1982; Legrand et al., 1983; Bhattacharyya and
Vassalle, 1982).
L-type calcium current blockade shortens the action
potential
(O’Hara et al., 2011)
Early depolarisation formation under hERG block (Guo et al., 2011)
Alternans formation at rapid pacing (Koller et al., 2005)
Conduction velocity of ca. 65 m/s (Taggart et al., 2000)
Validation
Action potential accommodation (Franz et al., 1988)
S1-S2 restitution (O’Hara et al., 2011)
Drug blocks and action potential duration (Dutta et al., 2017a; O’Hara et al., 2011)
Hyperkalemia promotes postrepolarisation refractoriness (Coronel et al., 2012)
Hypertrophic cardiomyopathy phenotype (Coppini et al., 2013)
Drug safety prediction using populations of models (Passini et al., 2017)
Physiological QRS and QT intervals in ECG (Engblom et al., 2005; van Oosterom et al., 2000; Bousseljot et al., 1995;
Goldberger et al., 2000)
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well as the INa, IKr, IK1 and chloride currents. The multiobjective genetic algorithm optimisation was
repeated several times, throughout the introduction of structural changes to the model. Once simu-
lations with an optimised model fulfilled all calibration criteria, validation was conducted through
evaluation against additional experimental recordings for drug block, disease, tissue and whole-ven-
tricular simulations.
Details concerning the simulations are given in Appendix 1-15.1, namely the description of simu-
lation protocols and ionic concentrations used (Appendix 1-15.1.1), representation of heart disease
(Appendix 1-15.1.2), 1D fibre simulations (Appendix 1-15.1.3), population-of-models and drug safety
assessment (Appendix 1-15.1.4), transmurality and whole-heart simulations with ECG extraction
(Appendix 1-15.1.5), and a technical note on the update to the Matlab ODE solver which facilitates
efficient simulation of the multiobjective GA (Appendix 1-15.1.6). Unless specified otherwise, the
baseline ORd model (O’Hara et al., 2011) was used for comparison with the ToR-ORd model.
ToR-ORd model structure
The ToR-ORd model follows the general ORd structure (Figure 1A). The cardiomyocyte is subdi-
vided into several compartments: main cytosolic space, junctional subspace, and the sarcoplasmic
reticulum (SR, further subdivided into junctional and network SR). Within these compartments are
placed ionic currents and fluxes described by Hodgkin-Huxley equations or Markov models. The
main ionic current formulations altered compared to ORd are highlighted in orange in Figure 1A.
In-depth revision of the L-type calcium current
The ICaL current was deeply revisited, particularly with respect to its driving force, based on biophysi-
cal principles. This reformulation is of relevance to almost all models of cardiac electrophysiology.
The ICaL formulation in the ORd model is based on Hodgkin-Huxley equations, with the total cur-
rent being a product of three components: 1) Open channel permeability, 2) A set of gating varia-
bles determining the fraction of channels being open, 3) The electrochemical driving force which
acts on ions to move through the open channel based on the membrane potential and ionic concen-
trations on both sides of the membrane (more details in Appendix 1-5). In most Hodgkin-Huxley
models of cardia currents, the driving force is computed as (V-Eion), that is, the membrane potential
minus equilibrium potential, either computed from the Nernst equation, or measured experimen-
tally. However, starting with the Luo-Rudy model (LRd) of 1994 (Luo and Rudy, 1994), the driving
force of ions via ICaL in cardiac models is modelled based on the Goldman-Hodgkin-Katz (GHK) flux
equation. The driving force based on the GHK equation is:










where z is the charge of the given ion, V is the membrane potential, F,R,T are conventional thermo-
dynamic constants, and [S]i, [S]o are intracellular and extracellular activities of the given ionic specie.
S½  ¼ g m, where g is the ionic activity coefficient and m the concentration (in either the intracellular
or extracellular space, yielding S½ i or S½ o).
Determining ionic activity coefficients
In order to compute the ionic driving force via the GHK equation, it is necessary to know the ionic
activity coefficients of the intracellular (gi) and extracellular (go) space. The Luo-Rudy model and
other Rudy-family models use go = 0.341 for extracellular space and gi = 1 for the intracellular space.
Models based on the Shannon model (Shannon et al., 2004) use 0.341 for both intracellular and
extracellular space, but we were unable to find the motivation for this change.
The Debye-Hückel theory is commonly used to compute the activity coefficients. We used the
Davies equation, which extends the basic Debye-Hückel equation to be accurate for ionic concentra-
tions found in living cells (Mortimer, 2008):







p   0:3  I
 
;
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Figure 1. Model structure. (A) A schematic of the novel human ventricular myocyte model for electrophysiology and calcium handling. Orange
indicates components, substituted, or added, compared to the original ORd model. ‘SS’ indicates junctional subspace compartment, where calcium
influx via L-type calcium current occurs and where calcium is released from the sarcoplasmic reticulum. ‘JSR’ and ‘NSR’ are junctional and network
sarcoplasmic reticulum compartments, respectively. ‘Main cytosolic pool’ is the remaining intracellular space. Transmembrane currents are indicated
with an ‘I’ in their name, with fluxes indicated as ‘J’. Components with a green underscore are modulated by CaMKII signalling. (B) The structure of the
Lu-Vandenberg (Lu et al., 2001) Markov model used for the rapidly activating delayed rectifier repolarisation current (IKr). The transition rates are given
in Appendix 1-15.3.5.
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where A is a constant (~0.5 for water at 25˚C, ~0.5238 at 37˚C), zi is the charge of the respective ion,
and I is the ionic strength of the solution. The ionic strength is defined as:
I ¼ 0:5 
i
X
mi  z2i ;
where mi is the concentration of the i-th ionic specie present. For concentrations in a study measur-
ing properties of ICaL (Magyar et al., 2000), I is ca. 0.15-0.17. This warrants the use of Davies equa-
tion, which was shown to be accurate for I up to 0.5, unlike the basic Debye-Hückel equation, which
is accurate for I up to 0.01 only (Mortimer, 2008).
We implemented the computation of ionic coefficients based on the Davies equation dynamically,
so that the activity coefficients are estimated at every simulation step. This allows accurate represen-
tation of the driving force when ionic concentrations are disturbed, such as at varying pacing rates,
or during homeostatic imbalance. The dynamic computation is also used to estimate ionic activity
coefficients for potassium and sodium flowing through the calcium channels, taking into account
their different charge.
Throughout our simulations, both intracellular and extracellular activity coefficients generally lie
between 0.61 and 0.66. Importantly, this estimate shows that the intracellular and extracellular activ-
ity coefficients are relatively similar (corresponding to the broadly similar total concentration of
charged molecules), in contrast with the original values. Particularly, the origin of the intracellular
activity coefficient gi = 1 in the Luo-Rudy model is unclear, as by the Davies (or by any Debye-Hückel
variant) equation, I would have to be zero, which is possible only when there are no ions present.
Activation curve extraction
An additional improvement in the ICaL formulation is the estimation of its activation curve. In brief,
we implement a consistent use of the GHK equation for the extraction of the activation curve and
for the ICaL formulation in the ToR-ORd model. The activation curve is obtained via dividing the
experimentally measured I-V relationship of the current by the expected driving force for each pulse
potential (see Appendix 1-3 for a graphical overview of the process). However, we identified a theo-
retical inconsistency in previous cardiac models across species (e.g. Luo and Rudy, 1994;
Hund et al., 2008; O’Hara et al., 2011; Shannon et al., 2004; Grandi et al., 2010; Carro et al.,
2011): whereas the Nernstian driving force of (V-ECa) is used to derive the activation curve, the GHK
driving force is then used to calculate ICaL. Indeed, experimental studies reporting the activation
curve of ICaL generally use the Nernstian driving force of (V-ECa) with ECa being the
experimentally measured reversal potential of approximately 60 mV. This is explicitly stated in
Linz and Meyer (2000), and also the activation curve by Magyar et al. (2000) used in the ORd
model is consistent with dividing the IV relationship with (V-60).
In this study, we propose that, for consistency, the same equation needs to be applied both to
obtain the activation curve from the I-V curve and to represent the driving force in the current formu-
lation. Thus, in the ToR-ORd model, the activation curve for ICaL was obtained by dividing the I-V
curve from Magyar et al. (2000) by the GHK-based driving force, computed using ionic activity
coefficients based on the Davies equation (as explained in the previous Section) and intracellular and
extracellular ionic concentrations as in Magyar et al. (2000). The following capped Gompertz func-
tion (a flexible sigmoid) was found to be the best fit to the resulting steady-state activation curve:
d¥ ¼ 1:0763  e 1:007e
 0:0829V
for V  31:4978 j1 otherwise
 
;
where V is the membrane potential.
Other ICaL changes
20% of ICaL was placed in the main cytosolic space, consistent with the literature (Scriven et al.,
2010). This increases the plateau-supporting capability of ICaL, given that the myoplasmic ICaL is sub-
ject to a weaker calcium-dependent inactivation than ICaL in the junctional subspace. Other minor
changes are given in Appendix 1-15.3.3.
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IKr replacement
The calibration of the ToR-ORd model’s AP morphology to experimental data resulted in problem-
atic response to calcium blockade during an early phase of the model development when the origi-
nal IKr formulation was used (further details in Appendix 1-12). ICaL block is known to shorten APD
experimentally (O’Hara et al., 2011) but resulted in a major APD prolongation in simulations
instead. This discrepancy could not be resolved through parameter optimisation. A mechanistic anal-
ysis revealed that this follows from the lack of ORd IKr activation, which is however not consistent
with relevant experimental data (Lu et al., 2001). We therefore considered alternative IKr formula-
tions and specifically the Lu-Vandenberg (Lu et al., 2001) Markov model (Figure 1B). The Lu-Van-
denberg IKr model is based on extensive experimental data allowing the dissection of activation and
recovery from inactivation and provided the best agreement with experimental data, specifically
when considering the AP plateau potentials reported experimentally. In Appendix 1-12, we: (1) pro-
vide a detailed explanation of origins of AP prolongation following ICaL block in a model which mani-
fests experimental data-like plateau potentials and which contains the ORd IKr formulation; (2)
explain why this phenomenon occurs only in a model with experimental data-like plateau potentials,
but not in the original high-plateau ORd model; (3) compare the ORd and Lu-Vandenberg IKr formu-
lations with experimental data, demonstrating the good agreement with experimental data of the
Lu-Vandenberg formulation but not the ORd.
Following the inclusion of the Lu-Vandenberg IKr formulation, all models generated during model
calibration exhibited APD shortening in response to ICaL block.
Changes in INa, I(Ca)Cl, IClb and IK1
The INa current formulation was replaced by an alternative human-based formulation (Grandi et al.,
2010), given established limitations of the original model with regards to conduction velocity and
excitability (O’Hara et al., 2011), comment on article from 05 Oct 2012). The Grandi INa model was
updated to account for CaMKII phosphorylation (Appendix 1-15.3.1).
Also from the Grandi model, we added the calcium-sensitive chloride current I(Ca)Cl and back-
ground chloride current IClb formulation (Grandi et al., 2010). Neither model was changed com-
pared to the original formulations, but the intracellular concentration of Cl- was slightly increased
(Appendix 1-15.1.1). In accordance with recent observations, I(Ca)Cl was placed in the junctional sub-
space (Magyar et al., 2017). The motivation to add these currents was to facilitate the shaping of
post-peak AP morphology (via I(Ca)Cl), with IClb playing a dual role stemming from its reversal poten-
tial of ca.  50 mV. It slightly reduces plateau potentials during the action potential, but during the
diastole, it depolarises the cell slightly, improving the reaction to IK1 block as explained in the next
subsection.
The IK1 model was replaced with the human-based formulation by Carro et al. (2011), as it was
shown to be key for simulations of hyperkalemic conditions. The IK1 replacement was done before
hyperkalemia simulation, not violating the classification of hyperkalemia criterion as a validation
step. Extracellular potassium concentration in a healthy cell was reduced from 5.4 to 5 mM to fall
within the physiological range (Zacchia et al., 2016).
Calibration of IK1 block and resting membrane potential
When evaluating the baseline ORd model against the selected criteria, we observed that a reduction
in IK1 results in hyperpolarisation of the cell (from  88 to  88.16 mV at 1 Hz pacing). However, it is
established that IK1 reduction depolarises cells experimentally (Dhamoon and Jalife, 2005). Changes
made during ToR-ORd calibration (predominantly the altered balance of currents during diastole
and the inclusion of background chloride current) result in ToR-ORd manifesting depolarization in
response to IK1 block, consistent with experimental data.
Multiobjective genetic algorithm
We applied a multiobjective genetic algorithm (MGA, @gamultiobj function in Matlab, Deb, 2001)
to automatically re-fit various model parameters. Based on preliminary experimentation, we used a
two-dimensional fitness. We used MGA rather than an ordinary genetic algorithm or particle swarm
optimisation, given that MGA optimises towards a Pareto front rather than a single optimum, implic-
itly maintaining population diversity. The Pareto front is the set of all creatures which are not
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dominated by any other creature in the population, that is creatures for which there is no other crea-
ture better in all fitness dimensions. Therefore, a subpopulation of diverse solutions is maintained,
and the optimiser consequently has less of a tendency to converge to a single local optimum com-
pared to single-number fitness approaches. In addition, the crossover operator of GA is well suited
for a task where multiple criteria are optimised, given that creatures in the population may efficiently
share partial solutions to various subcriteria. The fitness used in this study is described in greater
detail in Appendix 1-1.
Evaluation pipeline and code
To facilitate the model validation and future work, we also provide an automated ‘single-click’ evalu-
ation pipeline. It runs automatic simulations to extract and visualise single-cell biomarkers including
those related to AP morphology, effect of key channel blockers, early afterdepolarisations (EAD),
and alternans measurement. The pipeline generates a single HTML report containing all the results;
see Appendix 1-15.2 for a visualisation. The code for our model (Matlab and CellML), the validation
pipeline, and the experimental data on human AP morphology are available at https://github.com/
jtmff/torord (Tomek, 2019; copy archived at https://github.com/elifesciences-publications/
torord). An informal blog giving further insight into the choices we made, as well as general thoughts
on the development of ToR-ORd and computer models in general, is available at https://underlid.
blogspot.com/.
We designed the Matlab code used to simulate our model so that the simulation core is struc-
tured into functions computing currents, making the high-level organisation of code clear, and facili-
tating inclusion of alternative current formulations. In addition, a CellML file encoding our model is
also provided. This makes the model readily runnable in several simulators in addition to Matlab
(e.g. Chaste [Pitt-Francis et al., 2009] and OpenCOR [Garny and Hunter, 2015]). Furthermore, the
Myokit library (Clerx et al., 2016) enables conversion of the CellML file to other languages (such as
C or Python).
Results
Calibration based on AP, calcium transient, and L-type calcium current
properties
The AP morphology of the ToR-ORd is within or at the border of the interquartile range of the
Szeged-ORd experimental data (Figure 2A). This is a major improvement compared to the original
ORd morphology, which overestimates plateau potentials, particularly during early plateau
(Figure 2A). The fact that the early plateau potential is around 20–23 mV is clearly apparent from
experimental recordings and is further corroborated by additional studies in human tissue samples
(Jost et al., 2013, Figure 6) and isolated human cardiomyocytes (Coppini et al., 2013). We note
that compared to the Szeged-ORd dataset (Britton et al., 2017), our model manifests a slightly
increased peak membrane potential in the single-cell form, similar to single-cell experimental data
(Coppini et al., 2013). This is a design choice related to the fact that the Szeged-ORd dataset con-
tains recordings of small tissue samples, which are expected to manifest a reduced peak potential
compared to single-cell. When coupled in a fibre, ToR-ORd manifests conduction velocity of 65 cm/
s, which is consistent with clinical data (Taggart et al., 2000).
Both time to peak calcium and duration of calcium transient at 90% recovery obtained with the
ToR-ORd model are within the standard deviation of experimental data in isolated human myocytes
(Coppini et al., 2013), whereas ORd slightly overestimated the calcium transient duration
(Figure 2B). The calcium transient amplitude of ToR-ORd also matches the Coppini et al. data after
accounting for the different APD (Appendix 1-8).
As described in Materials and methods, the ToR-ORd ICaL activation curve was extracted from
experimental data, using the Goldman-Hodgkin-Katz formulation of ionic driving force, ensuring the-
oretical consistency, unlike the ORd ICaL formulation (Figure 2C). This considerably improves the
results of simulated protocols to obtain IV relationship (Figure 2D), validating the theory-driven
changes (see Appendix 1-4 for the demonstration of how the updated activation curve underlies the
improvement). The simulation of the protocol measuring steady-state inactivation also reveals
improved agreement of ToR-ORd with experimental data compared to ORd (Figure 2E). The
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difference between measured ORd steady state inactivation and the experimental data (ca. two
times stronger inactivation at around  15 mV, which is relevant for EAD formation) is initially surpris-
ing, given that the equation of ORd ICaL steady-state inactivation curve provides a good fit to the
same experimental data. This difference follows from the formulation of calcium-dependent inactiva-
tion of ICaL (see Appendix 1-5 for details).
We observed that in cases of elevated ICaL (e.g. in midmyocardial cells), ORd reverses current
direction towards positive values, which is an unexpected behaviour given its reversal potential of 60
Figure 2. Action potential, calcium transient, and ICaL in ToR-ORd. Action potential (A) and calcium transient (B) at 1 Hz obtained with the ToR-ORd
model following calibration, compared to those obtained with the ORd model and experimental data from O’Hara et al. (2011) and Coppini et al.
(2013), respectively. The purple and green zones in (B) stand for mean ± standard deviation. The duration of calcium transient at 90% recovery was
extracted from figures in Coppini et al. (2013), adding the time to peak and time from peak to 90% recovery. (C) Activation curves used in the ToR-
ORd and ORd models (blue and red lines, respectively). The points correspond to the IV relationship measured in Magyar et al. (2000) normalised by
the Nernstian driving force (d.f.) assuming reversal potential of +60 mV (blue points) and the GHK driving force (red points). (D, E) I-V relationship and
steady-state inactivation as measured in ToR-ORd (red line) versus ORd model (blue line) versus experimental data from Magyar et al. (2000) (black
points with line). ICaL,tot is the sum of currents corresponding to all ions (Ca
2+, Na+, and K+) passing through the L-type calcium current channels. (F)
L-type calcium current of a midmyocardial cell, showing current reversal in ORd, but not in ToR-ORd. Only the calcium component of ICaL,tot is shown to
demonstrate that the current reversal is not due to other ions. We note that the difference in total amplitude of ICaLin Figure 2F follows predominantly
from different action potential shape in ToR-ORd vs ORd, consistent with the I-V relationship.
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mV. Conversely, the ToR-ORd model yields negative ICaL values in such conditions, consistent with it
being an inward current (Figure 2F). This is a direct consequence of the updates to the extracellular/
intracellular calcium activity coefficients (as explained in Appendix 1-6), which supports their credibil-
ity and it is important for cases of elevated ICaL, such as under ß-adrenergic stimulation.
We have also simulated a P2/P1 protocol as measured experimentally by Fülöp et al. (2004),
where two rectangular pulses are applied with varying interval between them. Both ORd and ToR-
ORd qualitatively agree with the experimental data (Appendix 1-7).
Calibration: inotropic effects of sodium blockers
Figure 3A-D illustrates AP and calcium transient changes caused by block of sodium currents in
ToR-ORd (left) and ORd (right). As sodium blockers act on channel Nav1.5 mediating both the fast
(INa) and late (INaL) sodium current (Makielski, 2016), we simulate the effect of combined partial INa
and INaL block. The ToR-ORd model manifests a small reduction in calcium transient amplitude
(Figure 3C), unlike ORd, which gives a sizeable increase (Figure 3D); ToR-ORd is thus consistent
with the observed negative inotropy of sodium blockers (Gottlieb et al., 1990; Tucker et al., 1982;
Legrand et al., 1983; Bhattacharyya and Vassalle, 1982). This is a major improvement in the ToR-
ORd model, as sodium current reduction is involved in a range of disease conditions in addition to
pharmacological block.
Experimental evidence shows that the ratio of INa and INaL block is drug and dose-dependent,
with INaL usually being blocked more than INa (Appendix 1-9). Figure 3E,F illustrates the change in
calcium transient amplitude obtained with the ToR-ORd and ORd models, respectively, for several
combinations of INa and INaL availability. Both models show a similar general trend where reduced
INa availability increases calcium transient amplitude and reduced INaL availability diminishes it; how-
ever, the models differ strongly in relative contributions of these components. The ToR-ORd model
shows negative inotropy for almost all combinations of blocks. A mild increase in inotropy may be
achieved only under near-exclusive INa block. Conversely, ORd shows a general tendency for
increased calcium transient amplitude; a reduction occurs only when the sodium current block tar-
gets near-exclusively INaL. ToR-ORd presents a greater calcium transient amplitude reduction than
ORd in response to INaL block, as the current has a greater role in indirect modulation the cell’s cal-
cium loading via APD change. At the same time, ToR-ORd shows a much smaller calcium transient
amplitude increase in response to INa block than ORd because of the updated ICaL activation curve
(Figure 2C), as well as closer-to experimental data AP morphology (Figure 2A) and its effect on ICaL.
A detailed explanation is given in Appendix 1-10.
Fibre simulations carried out to assess the effect of cell coupling on the effect of sodium block
are consistent with the single-cell simulations (Appendix 1-11). The difference in response to half-
block of INa and INaL between ToR-ORd and ORd is even larger, as ToR-ORd in fibre predicts a
greater reduction in calcium transient amplitude than in single cell ( 14% vs  6% respectively), while
ORd in fibre predicts a slightly greater increase in calcium transient amplitude than in single cell
(+25% vs +24%).
With the ToR-ORd model, the 14% reduction in CaT amplitude in the electrically coupled fibre
with 50% block of both INa and INaL is generally consistent with clinical data on sodium blockers:
Encainide reduced stroke work index by 15% and cardiac index by 8% (Tucker et al., 1982). In
another study using encainide, the cardiac index was reduced by 18% and the stroke volume index
by 28% (Gottlieb et al., 1990). Flecainide reduced left ventricular stroke index by 12% and the left
ventricular ejection fraction by 9% (Legrand et al., 1983). Simulations with the ToR-ORd model
show overall agreement with the clinical data. However, a direct quantitative comparison is challeng-
ing given the different indices of contractility measured (CaT amplitude versus clinical indices) and
that it is not possible to estimate the exact ratios of INa and INaL block in clinical data (Appendix 1-9).
Calibration: proarrhythmic behaviours (alternans and early
afterdepolarisations)
EADs are an important precursor to arrhythmia, manifesting as a membrane potential depolarisation
during late plateau and/or early repolarisation. They are thought to arise mainly from ICaL current
reactivation (Weiss et al., 2010). The ToR-ORd model manifests EADs at conditions used experi-
mentally in nondiseased human endocardium (Guo et al., 2011; Figure 4A). The amplitude of
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simulated EADs is 14 mV (Figure 4B), which matches the maximum EAD amplitude shown by
Guo et al. (2011). We also note that the experimental data by Guo et al. manifest early plateau
potential of ca. 23 mV (which is matched by ToR-ORd), in line with other studies we referred to pre-
viously regarding this matter.
Figure 3. Sodium blockade in ToR-ORd and ORd. Simulated effect of sodium current block on the action potential (A, B) and calcium transient (C,D)
using the ToR-ORd (left) and ORd (right) models. Control simulations are shown as blue traces, whereas results for 50% block of INa and INaL are shown
as red traces. Panels (E,F) show values of changes in calcium transient amplitude with respect to control (‘rel. CaTA’) for varying degrees of INa/INaL
block for ToR-ORd and ORd respectively (one is no change, values > 1 correspond to an increase the calcium transient amplitude).
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Repolarisation alternans is another established precursor to arrhythmia, facilitating the formation
of conduction block (Weiss et al., 2006). It is induced by rapid pacing and it is mostly thought to
arise from calcium transient amplitude oscillations being translated to APD oscillations
(Pruvot et al., 2004), although purely voltage-driven mechanism was also proposed (Nolasco and
Figure 4. EADs and alternans. (A) Experimentally observed EADs produced in nondiseased human myocytes exposed to 0.1 mM dofetilide (~85% IKr
block) paced at 0.25 Hz (Guo et al., 2011) and the corresponding simulation using the ORd model (O’Hara et al., 2011), figure reproduced as allowed
by the CC-BY license). See Appendix 1-15.1.1 for ionic concentrations used. (B) An EAD produced by the ToR-ORd model at the same conditions. (C,E)
APD and calcium transient amplitude versus pacing base cycle length (bcl); the bifurcation indicates alternans. (D,F) Example of APD and calcium
transient alternans at the bcl of 260 ms.
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Dahlen, 1968). Alternans in the ToR-ORd model is calcium-driven and appears via the same mecha-
nism as in the ORd: sarcoplasmic reticulum calcium cycling refractoriness (Tomek et al., 2018). It
occurs at rapid pacing, in both calcium and APD (Figure 4C–F). The peak APD alternans amplitude
(difference in APD between consecutive beats) is 12 ms, which is matches the value 11 ± 2 ms
reported in human hearts without a structural disease (Koller et al., 2005). Direct quantitative com-
parison is however slightly limited by the fact that the data were recorded in RV septum, which may
or may not differ from endocardial cells in alternans amplitude.
Validation: drug-induced effects on rate dependence of APD
Figure 5 illustrates simulations of drug action using the ToR-ORd model (red traces), compared to
experimental data (black traces) and to simulations with the ORd model reparametrised
Figure 5. Drug block and APD. All four panels contain mean and standard deviation of experimental data (black) as measured in O’Hara et al. (2011)
for three basic cycle lengths (bcl), predictions of the Dutta optimised dynamic-IKr ORd model (blue, Dutta et al., 2017a), and the predictions of the
ToR-ORd model (red). (A) 1 mM E-4031 (70% IKr block). (B) 1 mM HMR-1556 (90% IKs block). (C) 10 mM mexiletine (54% INaL, 9% IKr, 20% ICaL block). (D) 1
mM nisoldipine (90% ICaL block). Drug concentrations and their effects on channel blocks are based on Dutta et al. (2017b).
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by Dutta et al. (2017a) (blue dashed lines). APD is shown in the presence of IKr block (E-4031,
Figure 5A), IKs block (HMR-1556 Figure 5B), multichannel block of INaL, ICaL, IKr (mexiletine,
Figure 5C), and a ICaL block (nisoldipine, Figure 5D), at base cycle lengths of 500, 1000, and 2000
ms. We note that while the Dutta et al. model was specifically optimised for response of APD to
these drug blocks, no such treatment was applied to the ToR-ORd model, making the results pre-
sented here an independent validation. Appendix 1-13 contains further details on the choice and
use of the drug data.
The predictions produced by the ToR-ORd model are in good agreement with experimental
data, particularly given the lack of optimisation towards this result. Simulating E-4031, ToR-ORd pro-
vides a prediction similar to the experimental data mean and the Dutta model (Figure 5A). This is
crucial, given the key role of IKr in the repolarisation reserve of human cardiomyocytes. The response
to IKs blockade via HMR-1556 is even better in ToR-ORd than in the Dutta model, which is also within
standard deviation of the data, but carries a clear trend towards AP prolongation (Figure 5B). When
simulating the multichannel blocker mexiletine, ToR-ORd prediction is within standard deviation of
the experimental data, with the Dutta model giving similar or closer-to-mean predictions at 0.5 and
1 Hz (Figure 5C). The predicted effect of the calcium blocker nisoldipine in the ToR-ORd model
matches well the experimental data mean (Figure 5D), even better than the Dutta model (also within
standard deviation). We note that the good performance of the simulated nisoldipine effect critically
relies on the IKr replacement (Materials and methods and Appendix 1-12).
Validation: APD accommodation and S1-S2 restitution
Experimental measurements in human cardiomyocytes (Franz et al., 1988; Bueno-Orovio et al.,
2012) show how the APD shortens upon increase in pacing frequency, and then prolongs again, as
Figure 6. APD accommodation and S1-S2 protocol. (A) APD accommodation measured experimentally (Franz et al., 1988) and in simulation of the
ORd model (reproduced as allowed by the CC-BY licence from O’Hara et al., 2011). (B) APD accommodation in ToR-ORd. (C) S1-S2 restitution curve
(S1 = 1000 ms) in ToR-ORd fibre, ORd fibre (including INa modification to facilitate propagation Passini et al., 2016) and human tissue samples data
(O’Hara et al., 2011).
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the pacing frequency returns to control (Figure 6A, top). APD adaptation dynamics with changes in
heart rate are regulated by changes in sodium homeostasis (Pueyo et al., 2011), and their manifes-
tation in QT adaptation have been shown to be useful for arrhythmia risk prediction (Pueyo et al.,
2004). While simulations with the ORd model capture the general trend of APD accommodation,
there are differences compared to the experimental data (Figure 6A). First, changes in pacing rate
are followed by slow-dynamics (~30 s) APD prolongation not present in the experimental recordings.
Second, the time constant of accommodation is generally slow. Conversely, the ToR-ORd model
reproduces the pattern of accommodation well, where the change in APD soon after change in fre-
quency is relatively fast, and then gradually slows down (Figure 6B). This suggests that the ionic bal-
ance in ToR-ORd is likely to have been improved compared to ORd.
A second indicator of how a model responds to a change in pacing frequency is the S1-S2 restitu-
tion protocol. The S1-S2 restitution curve obtained with the ToR-ORd model is given in Figure
(Figure 6C), showing a good agreement with the experimental data (O’Hara et al., 2011).
Validation: populations of models and drug safety prediction
Drug safety testing is one of the key applications of computer modelling which has yielded highly
promising results (Passini et al., 2017). To assess the suitability of ToR-ORd for drug safety testing,
we replicated the study by Passini et al. (2017), which was carried out using populations of models
based on the ORd model. Two populations were created based on ToR-ORd similarly to the original
study, altering conductances of important currents within the ranges of 50–150% and 0–200%. Mod-
els in both populations are stable under significant perturbation of ionic conductances, which sup-
ports the robustness of the model (Figure 7A).
Prediction of the risk of drug-induced Torsades de Pointes based on simulated drug-induced
repolarisation abnormalities using ToR-ORd population yielded similar results to the original study,
with predicted risk being correct for 54 out of 62 compounds (87% accuracy). Compared to
Passini et al. (2017), the assessment of Mexiletine (a predominantly sodium blocker that is safe) was
improved from false positive to true negative. High-dose Mexiletine led to formation of many EADs
in ORd, but not in ToR-ORd (Figure 7B), highlighting the importance of the advances on sodium
blockers presented in this work. At the same time, Procainamide and Metrodinazole were misclassi-
fied as false negatives compared to Passini et al. (2017). However, these drugs are controversial, as
Metrodinazole is considered non-torsadogenic by Lancaster and Sobie (2016), and this study pre-
dicted both the drugs to be non-risky. Torsadogenic risk for all evaluated compounds and the confu-
sion matrix of the classification are given in Figure 7C.
Validation: response to disease
Hyperkalemia
Hyperkalemia, the elevation of extracellular potassium, is a hallmark of acute myocardial ischemia
caused by the occlusion of coronary artery. It was shown that hyperkalemia can significantly inhibit
sodium channel excitability following repolarisation, leading to the prolongation of postrepolarisa-
tion refractoriness (Coronel et al., 2012). The dispersion of effective refractory periods (ERPs)
between normal and ischemic zones forms a substrate for the initiation of re-entrant arrhythmia. In
this new model, we tested the effect of hyperkalemia on tissue excitability using 1D fibres. As shown
in Figure 8A, the elevation of extracellular potassium level led to an increase of the resting mem-
brane potential (RMP) and the decrease of AP upstroke amplitude. As a result of weaker upstroke
and more depolarised RMP, the APD shortened under hyperkalemia; however, the ERPs were pro-
longed due to the stronger sodium channel inactivation caused by the elevation of RMP (Figure 8B).
Therefore, this new model successfully reproduced the longer post-repolarization refractoriness
under hyperkalemia observed in experiments, and it can be used in the simulations of re-entrant
arrhythmia under acute ischemia. In this regard, it presents an improvement over the original ORd
model, which did not manifest postrepolarisation refractoriness without further modifications
(Dutta et al., 2017b).
Hypertrophic cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is among the most common cardiomyopathies, manifesting as
abnormal thickening of the cardiac muscle without an obvious cause (Coppini et al., 2013). Beyond
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Figure 7. Populations of models and drug safety prediction. (A) Percentile-based summary of AP and calcium transient traces for the two populations
of human ToR-ORd models (left side) and distribution of ionic current conductances among models in the population (right side), in the ranges [50-
150]% (top row) and [0–200]% (bottom row) of the baseline values. (B) A comparison of 0–200% populations based on ToR-ORd (left) and ORd (right,
based on Passini et al., 2017) in response to high-dose mexiletine (100-fold effective therapeutic dose). Traces classified as EADs are plotted in red
(manifesting only in the ORd population). (C) TdP score obtained for simulations of the 62 reference compounds, based on the occurrence of drug-
induced repolarisation abnormalities at all tested concentrations in the [0–200]% population of ToR-ORd models. The colours associated with drugs
signify their established torsadogenicity as specified in Appendix 1-15.1.4. The logarithmic scale was considered to maximise the visual separation
between safe and risky drugs. The classification based on the TdP score is summarised as a confusion matrix on the right, and also compared with the
corresponding results obtained in a population of models based on the original ORd model (Passini et al., 2017).
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mechanical remodelling, the disease predisposes the hearts to arrhythmia formation, increasing the
vulnerability to early afterdepolarisations. HCM induces complex multifactorial remodelling of cell
electrophysiology and calcium handling, making it a challenging validation problem for a computer
model. We applied the available human experimental data on HCM remodelling (based predomi-
nantly on Coppini et al., 2013) to our baseline model using an approach similar to Passini et al.
(2016), observing that the dominant features of the remodelling observed by Coppini et al. are cap-
tured. The HCM variant of the computer model corresponds to experimental data in the AP mor-
phology, manifesting a significantly higher plateau potential and an overall APD prolongation
(Figure 8C). The calcium transient amplitude of the HCM model is slightly reduced, has longer time
to peak, and a noticeably longer duration at 90% recovery (Figure 8D), also consistent with the data
by Coppini et al. (2013). Ultimately, the HCM variant of our model is more prone to the formation
of EADs (Figure 8E), as was shown experimentally (Coppini et al., 2013). This difference is in line
with postulated key role of ICaL and NCX in EAD formation (Luo and Rudy, 1994; Weiss et al.,
2010), both of which are markedly increased in HCM. Excessive prolongation of APD due to a
strong increase in late sodium current in HCM also contributes to the EAD formation as well, as
shown by Coppini et al. (2013).
Figure 8. Simulation of hypertrophic cardiomyopathy (HCM) and hyperkalemia. (A) The effect of hyperkalemia on AP morphology; measured in the
centre of a simulated fibre. (B) APD90 and effective refractory period (ERP) at varying extracellular potassium concentration. For extracellular potassium
higher than 9 mM, full AP did not develop, but low-amplitude activation propagated through the fibre (Appendix 1-14). Membrane potential (C) and
calcium transient (D) at 1 Hz pacing compared between a single healthy and HCM cell. (E) 50% IKr block induces EADs in HCM cell, but not in a healthy
one.
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Validation: human whole-ventricular simulations - from ionic currents to
ECG
We conducted 3D electrophysiological simulations using the ToR-ORd model, representing the
membrane kinetics of endocardial, epicardial and mid-myocardial cells to investigate their ability to
simulate the ECG (see Appendix 1-15.1.5). Transmural and apex-to-base spatial heterogeneities as
well as fibre orientations based on the Streeter rule were incorporated into a human ventricular ana-
tomical model derived from cardiac magnetic resonance (Lyon et al., 2018).
Figure 9A shows the resulting electrocardiogram computed based on virtual electrodes posi-
tioned on a torso model shown in Figure 9B. The ECG manifests a QRS duration of 80 ms (normal
range 78 ± 8 ms), and a QT interval of 350 ms (healthy:<430 ms); all of these quantitative measure-
ments are in the range of ECGs of healthy persons (Engblom et al., 2005; van Oosterom et al.,
2000). ECG morphology also showed normal features, such as R wave progression in the precordial
leads from V1 to V6, isoelectric ST segment, and upright T waves in leads V2 to V6, with inverted T
wave in aVR. Figure 9C shows the activation sequence is in agreement with Durrer et al. (1970).
The APD map shows longer APD in the endocardium and the base, and shorter APDs in the epicar-
dium and the apex, respectively (Figure 9D).
Discussion
In this study, we present a new model of human ventricular electrophysiology and excitation contrac-
tion coupling, which is able to replicate key features of human ventricular depolarisation, repolarisa-
tion and calcium transient dynamics. The ToR-ORd model was developed using a defined set of
calibration criteria and subsequently validated on features not considered during calibration to dem-
onstrate its predictive power. This article also unravels several important theoretical findings with
implications for computational electrophysiology reaching beyond the ToR-ORd model and cardiac
electrophysiology: firstly, the reformulation of the L-type calcium current, which is broadly relevant
and generally applicable to human and other species, and secondly, the mechanistically guided
replacement of IKr. Discovering the necessity to carry out these theoretical reformulations was
enabled by the comprehensive set of calibration criteria and the use of a genetic algorithm to fulfil
them. Finally, to enable reproducibility, we openly provide an automated model evaluation pipeline,
which provides a rapid assessment of a comprehensive set of calibration or validation criteria.
The AP morphology of ToR-ORd is in agreement with the Szeged endocardial myocyte dataset
used to construct the state-of-the art ORd model (O’Hara et al., 2011). The agreement is consider-
ably better than that of ORd itself, which has important implications for multiple aspects studied in
this work. The calcium transient also recapitulates key features of human myocyte measurements
(Coppini et al., 2013). The validation of ToR-ORd shows that the model responds well to drug block
with regards to APD (Dutta et al., 2017a). Good APD accommodation (reaction to abrupt, but per-
sisting changes in pacing frequency) indicates a good balance between ionic currents (Franz et al.,
1988; Pueyo et al., 2010). Replication of arrhythmia precursors such as early afterdepolarisations
(Guo et al., 2011) and alternans (Koller et al., 2005) makes the model useful for simulations and
understanding of arrhythmogenesis. This is particularly important in the context of heart disease,
where ToR-ORd is shown to replicate key features of hyperkalemia (Coronel et al., 2012) and hyper-
trophic cardiomyopathy (Coppini et al., 2013). The model is also shown to be promising in drug
safety testing, and whole-heart simulations demonstrate physiological conduction velocity
(Taggart et al., 2000) and produce a plausible ECG signal. Among the improved behaviours com-
pared to the state-of-the-art ORd model (O’Hara et al., 2011), the good response of the ToR-ORd
model to sodium blockade is particularly noteworthy. ToR-ORd predicts the negative inotropic effect
of sodium blockade, consistent with data (Gottlieb et al., 1990; Tucker et al., 1982;
Legrand et al., 1983; Bhattacharyya and Vassalle, 1982), unlike ORd, which suggests a strong
pro-inotropic effect. The improvement in ToR-ORd follows from the relatively complex interplay of
the theoretically driven reformulation of the L-type calcium current and data-driven changes to the
AP morphology. This result is of great importance in the context of pharmacological sodium block-
ers, but it also plays a crucial role in disease modelling, where both fast (Pu and Boyden, 1997) and
late (Coppini et al., 2013) sodium current are altered.
An important feature of a model is its predictive power, and validation of a model using data not
employed in model calibration is a central aspect of model credibility (Pathmanathan and Gray,
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Figure 9. Simulated and clinical 12-lead electrocardiogram. (A) 12-lead ECGs at 1 Hz: simulation using the ToR-ORd model in an MRI-based human
torso-ventricular model (top) and a healthy patient ECG record (bottom, https://physionet.org, PTB database, subject 122; Bousseljot et al., 1995;
Goldberger et al., 2000). (B) Electrode positions on the simulated torso. (C) Activation time map. (D) APD map.
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2018; Carusi et al., 2012). With this in mind, we designed our study to first calibrate the developed
model using a set of given criteria, with subsequent validation of the model using separate data that
were not optimised for during development. The fact that ToR-ORd manifests a wide range of
behaviours consistent with experimental studies, even though it was not optimised for these pur-
poses, suggests its generality and a large degree of credibility. To facilitate future model develop-
ment, we also created an automated ‘single-click’ pipeline, which evaluates a wide range of
calibration and validation criteria and creates a comprehensive HTML report. New follow-up models
can thus be immediately tested against criteria presented here, making it clear which features of the
model are improved and/or deteriorated by any changes made.
The greatest theoretical contribution of this work is the theory-driven reformulation of the L-type
calcium current, namely the ionic activity coefficients and activation curve extraction. Activation
curve of the current in previous cardiac models was based on the use of Nernst driving force in
experimental studies, but the models then used Goldman-Hodgkin-Katz driving force to compute
the current. This yields a theoretical inconsistency present in existing influential models of guinea
pig, rabbit, dog, or human, for example (Luo and Rudy, 1994; Hund et al., 2008; O’Hara et al.,
2011; Shannon et al., 2004; Grandi et al., 2010; Carro et al., 2011). We propose and demonstrate
that in order to obtain consistent behaviour, the experimental I-V relationship measurements are to
be normalised using the Goldman-Hodgkin-Katz driving force instead. Updated ionic activity coeffi-
cients and activation of the L-type calcium current improve key features of the current observed in
the study underlying the ORd L-type calcium current model (Magyar et al., 2000), and strongly con-
tribute to the improved reaction of the model to sodium blockade. The changes made are relevant
in development of future models which use the Goldman-Hodgkin-Katz equation for L-type calcium
current or other currents.
A second major contribution of this work reaching beyond the model itself is the set of observa-
tions on modelling of IKr, the dominant repolarising current in human ventricle. We noticed limita-
tions of the ORd IKr model, which may be a result of the single-pulse voltage clamp protocol to
characterise the current behaviour. Approaches enabling the dissection of activation and recovery
from inactivation based on more comprehensive experimental data, such as Lu et al. (2001) used in
our work, may yield a more general and plausible model. In this study, this change was important
predominantly for the response of the ventricular cell to calcium block, but our observations are
highly relevant also for models of cells with naturally low plateau, such as Purkinje fibres or atrial
myocytes.
We anticipate that the main future development of the presented model will focus on the ryano-
dine receptor and the respective release from sarcoplasmic reticulum. Similarly to most existing car-
diac models, the equations governing the release depend directly on the L-type calcium current,
rather than on the calcium concentration adjacent to the ryanodine receptors, which is the case in
cardiomyocytes. Future development of the ryanodine receptor model and calcium handling will
extend the applicability of the model to other calcium-driven modes of arrhythmogenesis, such as
delayed afterdepolarisations. Also, while the model represents to a certain degree the locality of ICaL
calcium influx and calcium release via the utilization of the junctional calcium subspace, a more direct
representation of local control (Stern, 1992; Hinch et al., 2004), realistic spatially distributed cal-
cium handling (Colman et al., 2017), or representation of stochasticity, may improve the insights the
model can give into calcium-driven arrhythmogenesis. However, we note that such changes (particu-
larly the detailed distributed calcium handling) will increase computational cost of the model’s simu-
lation. In addition, further research on the mechanisms regulating AP dependence on extracellular
calcium concentration is needed to update this feature, not currently reproduced by most current
human models (Passini and Severi, 2014).
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No new experimental data were created. However, codes for simulations are available at https://
github.com/jtmff/torord (copy archived at https://github.com/elifesciences-publications/torord).
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G, Csernoch L, Nánási PP, Szentandrássy N. 2017. Calcium activated chloride current in mammalian ventricular
myocytes. Biophysical Journal 112:36a. DOI: https://doi.org/10.1016/j.bpj.2016.11.227
Mahajan A, Shiferaw Y, Sato D, Baher A, Olcese R, Xie LH, Yang MJ, Chen PS, Restrepo JG, Karma A, Garfinkel
A, Qu Z, Weiss JN. 2008. A rabbit ventricular action potential model replicating cardiac dynamics at rapid heart
rates. Biophysical Journal 94:392–410. DOI: https://doi.org/10.1529/biophysj.106.98160, PMID: 18160660
Makielski JC. 2016. Late sodium current: a mechanism for angina, heart failure, and arrhythmia. Trends in
Cardiovascular Medicine 26:115–122. DOI: https://doi.org/10.1016/j.tcm.2015.05.006
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Pueyo E, Husti Z, Hornyik T, Baczkó I, Laguna P, Varró A, Rodrı́guez B. 2010. Mechanisms of ventricular rate
adaptation as a predictor of arrhythmic risk. American Journal of Physiology-Heart and Circulatory Physiology
298:H1577–H1587. DOI: https://doi.org/10.1152/ajpheart.00936.2009, PMID: 20207815
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Appendix 1
1. Calibration criteria
This section provides additional information to the criteria listed in Table 1.
The AP morphology was based primarily on the large experimental dataset of human
undiseased endocardial recordings from the Varró lab, published in Britton et al. (2017). The
ORd model (O’Hara et al., 2011) was based on a subset of these recordings. We aimed for
similarity with the median of the AP data during the plateau and repolarization phase (from 15
ms after the AP peak). Two other datasets were used to confirm that early plateau potentials
are ca. 20 mV, rather than the >30 mV as in ORd (Coppini et al., 2013; Jost et al., 2013).
The calcium transient morphology (CaT amplitude and duration at 90% recovery) was
based on Coppini et al. (2013), particularly given it is clear that the AP morphology is similar
in their experimental recordings and the simulations with the TOR-ORd model. The aim was
for the two CaT properties to lie within standard deviation of mean. A correction for the
difference in APD with regards to CaT amplitude was made in Appendix 1-8.
The properties of ICaL, the I-V relationship and steady-state inactivation were taken as
reported in Magyar et al. (2000), as this is the primary dataset used in the ORd ICaL
construction. Visual assessment of simulations versus data was used.
Negative inotropy of sodium blockers was based on Gottlieb et al. (1990); Tucker et al.
(1982); Legrand et al. (1983); Bhattacharyya and Vassalle (1982), which report 8–28%
reduction in whole-heart contractility, depending on drug, dose and index of contractility.
Given the variability, throughout the calibration of a single-cell model, we aimed for any
reduction in CaT amplitude following 50% reduction of INa and INaL.
The blockade of ICaL is known to shorten APD across species, including human
(O’Hara et al., 2011). Within the process of calibration, we aimed for any APD shortening at
50% ICaL reduction.
EADs were shown to form under ca. 85% IKr block in human myocytes at 0.25 Hz pacing
(Guo et al., 2011). Thus, we aimed for the new model to manifest EADs of similar amplitude
as in the data (ca. 14 mV) in corresponding conditions.
APD alternans was observed in undiseased human cells at rapid pacing (Koller et al.,
2005). We aimed for a model manifesting APD alternans, with the onset at basic cycle length
shorter than 300 ms.
The reported conduction velocity in human heart is 65 m/s (Taggart et al., 2000), and we
compared this value to the result of a fibre simulation using the developed ToR-ORd model.
2. Genetic algorithm fitness
The fitness function has 18 inputs, 16 of which are the multipliers of conductances for the
following currents and fluxes: INa, ICaL, Ito, INaL, IKr, IKs, IK1, IKb, INaCa, INaK, INab, ICab, IpCa, ICaCl,
Jrel, Jup. Also varied were K¥,Rel, a parameter of Jrel (constrained between 0.9 and 1.7) and the
fraction of INaCa in the junctional subspace (constrained between 0.18 and 0.4).
If the genetic algorithm (GA) employed symmetric percentual variations of raw current
multipliers (e.g., + /- 50%), it would not sample the input space evenly – for example, a
symmetric Gaussian mutation is much more likely to halve a parameter than to double it
(assuming the Gaussian curve being centred at 1, the density in 0.5 is the same as in 1.5, but
not in 2), while the likelihood should be arguably the same. The initial population would also
likely be highly skewed towards current reduction. In order to avoid these issues, we made the
GA work internally with logarithms of multipliers, which makes the sampling symmetrical (-log
(0.5)=log(2), etc.). The fitness function first exponentiates the log-multipliers to obtain the
actual multipliers, and these are subsequently used in further simulation.
Within the fitness function, the evolved model is pre-paced for 130 beats at 1 Hz, with the
final state X130. Subsequently, 20 more beats are simulated at the following conditions, with
X130 as the starting state: a) no change to parameters, b) sodium blockade (50% INa block,
50% INaL block), c) calcium blockade (50% ICaL block), d) IK1 blockade (50% block). 150 beats in
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total for the control condition is a compromise between total runtime and similarity to the
stable-state behaviour. The 20 beats at various conditions following 130 beats of prepacing
are sufficient to manifest the effects of the respective blocks , while keeping the runtime
low (When the model is evaluated in the manuscript, the outputs are based on 1000 beats of
pre-pacing; the 150 or 130+20 beats are used only during model refitting to allow sufficiently
fast runtime.).
Based on these simulations, a two-element fitness vector is obtained; the first element
describes similarity of action potential (AP) morphology to the reference, with the second
element aggregating other criteria (calcium transient duration and amplitude, calcium
transient amplitude reduction with sodium blockade, action potential duration (APD) reduction
with calcium blockade, and a depolarisation with IK1 block).
Not all calibration criteria (Table 1) were represented in the fitness function, as simulating
all corresponding protocols would be prohibitively slow. Instead, the calibration criteria not
optimized using the genetic algorithm were subsequently fulfilled by mechanistically informed
manual changes, while making sure the already optimised criteria were not violated.
3. Extraction of ICaL activation from I-V relationship
The experimental protocol to measure I-V relationship of the ICaL uses square pulse stimuli to
measure peak current for different pulse potentials (Appendix 1—figure 1, top left). The peak
current can be seen as the product of two components: activation (how open the channels are)
and driving force (the strength of the diffusion and electrical gradients that produce ionic flow
through the open channels). To obtain the activation value for each pulse potential, the
corresponding peak current is divided by the theoretical estimate of the driving force. The
resulting curve can then be scaled to 0–1, producing estimated fractional activation
(Appendix 1—figure 1, top right). The driving force may be computed based on the linear
equation V-ECa, or the nonlinear Goldman-Hodgkin-Katz (GHK) flux equation (Appendix 1—
figure 1, bottom left and bottom right, respectively). This yields the two corresponding
activation curves in Appendix 1—figure 1, top right.
Appendix 1—figure 1. Diagram of how activation curves are extracted from the I-V relationship.
The activation curves (top right) are obtained by dividing values in the I-V curve (top left) at
each pulse potential by the driving force considering either V-ECa-based driving force (bottom
right) or the Goldman-Hodgkin-Katz (GHK) flux equation (bottom left).
Appendix 1—figure 1 can be also used to illustrate the theoretical inconsistency in the
ORd model and many other models (e.g. Luo and Rudy, 1994; Hund et al., 2008;
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O’Hara et al., 2011; Shannon et al., 2004; Grandi et al., 2010; Carro et al., 2011): the V-ECa
driving force is used to obtain the activation curve, but then the ICaL is computed using the
GHK driving force, which does not yield the original data, as illustrated in the Results section.
Returning to the notion of I-V relationship as a product of activation and driving force, the
same shape of I-V relationship can be obtained by pointwise multiplication of the blue driving
force (bottom, left) with blue activation (top, right), or the red driving force (bottom, right)
with red activation (top, right). However, simulating the I-V relationship using the ORd model
corresponds to the product of blue activation and the red driving force, which then naturally
does not match greatly the original I-V relationship (Figure 2D, or Appendix 1—figure 2 in
Appendix 1-4).
Appendix 1—figure 2. Effect of the proposed changes in the activation curve and activation
coefficient on the I-V relationship of ICaL in ORd versus ToR-ORd.
4.ICaL updates and the I-V relationship
Appendix 1—figure 2 illustrates the effect that updates in activation curve and activation
coefficients have on the simulated ICaL I-V relationship considering four models:
. Control ORd
. ORd with updated activity coefficients as in ToR-ORd (fixed to 0.6532/0.6117 for intracellu-
lar/extracellular calcium, 0.89/0.88 for intracellular/extracellular sodium; the same also for
potassium)
. ORd with updated activation curve as in ToR-ORd . ToR-ORd model.
The I-V curves were normalised to a minimum of  1, in order to focus on the shape of the
I-V curve rather than its amplitude (which is modulated by maximal conductance). Considering
the new activation curve extracted using the GHK equation in the ORd model yields a near-
identical I-V curve to the ToR-ORd model (Appendix 1—figure 2). This demonstrates this is
the key mechanism in the I-V curve improvement. The update of activity coefficients did not
alter the shape of the I-V relationship noticeably compared to the ORd model (Appendix 1—
figure 2), but played a key role in avoiding the reversal of ICaL illustrated in Figure 2F and a
good response to sodium block, as explained in the next section.
5. Extraction of steady-state inactivation of ICaL
As shown in Figure 2E of the main manuscript, the steady-state inactivation curve of the ORd
model differs from the experimental data. This is surprising, given that both the steady state
voltage and calcium inactivation in the model are a direct fit to the experimental data. The
explanation of this phenomenon lies in the construction of the ICaL equation in the ORd model,
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which is as follows (only the non-phosphorylated part is given; the phosphorylated is
analogous):
ICaL; NP ¼ ICaL
 
 d  f  1  nð Þþ fCa  n  jCað Þ
where ICaL
 
is the product of driving force and channel conductance, d is activation, f is
voltage-driven inactivation, n is a weight of calcium inactivation, fCa is calcium-driven
inactivation, and jCa corresponds to recovery from inactivation. In the ORd model, stable-state
values of f ; fCa; jCa are all fit to the steady-state inactivation in Magyar et al. (2000). During a
long voltage clamp pulse used to inactivate ICaL, ICaL
 
and d can be assumed to be constant,
leaving the remaining parentheses as the factor determining measured inactivation. If jCa was
equal to 1, then the equation would reduce to the experimentally observed inactivation in the
steady state (however, this prevents formation of EADs). However, given that jCa effectively
acts as a second inactivation, the jCa  fCa product corresponds to a square of the
experimentally observed inactivation, making the inactivation stronger. Thus, for n>0, this ICaL
model manifests total steady-state inactivation stronger than the one from Magyar et al.
(2000).
As shown in Figure 2E of the main manuscript, this problem is not present in the ToR-ORd
model, which yields a better match with experimental data than ORd. Inspecting state
variables at the inactivating pulse potentials where the models differ (approximately between -
30 and -5 mV), we observed that the ORd model has a higher level of calcium in the subspace,
increasing the value of the n variable, making the contribution of the overestimated
inactivation stronger. The higher calcium level in the subspace in the ORd model seems to
arise from a combination of two factors: (1) Overestimated activation and thus enhanced
calcium entry in ORd (evident from Figure 2 C, D in the main manuscript), accompanied by
small differences in Jrel formulation translating into more SR release in ORd; (2) less total NCX
in the subspace, corresponding to less calcium clearance.
It is worth noting that the exact shape of the simulation-based inactivation curve depends
on how exactly the conditions in Magyar et al. (2000) are represented. As explained in
Appendix 1-15.1.1, intracellular and potassium are fixed when the steady-state inactivation is
measured, but calcium is not fixed. If the intracellular calcium in the model was also clamped
to the zero concentration of the pipette, n would be zero and both ORd and ToR-ORd would
fit the inactivation curve well.
6. ICaL reversal and ionic activity coefficients
As illustrated in Figure 2F, the ToR-ORd model yields a consistently inward ICaL during the AP,
whereas for the ORd, there is a reversal to outward ICaL following the peak of the AP. For the
ORd midmyocardial cell, ICaL is highly positive (ICaL = 3.32 pA/pF) at t = 4.3 ms. This can be
explained by the update in the ionic activity coefficients described in section Methods:
Determining ionic activity coefficients. The sign of ICaL is determined by the sign of the driving
force (other components of ICaL are the permeability constant, and gating variables, both of
which are nonnegative). The GHK equation for driving force (with all elements explained in
Materials and methods of the main manuscript) can be divided into four components for
clarity (Appendix 1—figure 3). Components 1 and 4 are positive (V = 33 mV at this point of
simulation) and thus do not affect the sign; therefore, the sign of the driving force in this case
is determined by the relative size of components 2 and 3. In control ORd (with activity




RT ¼ gi mi  e
zV F
RT ¼ 1  0:0822  11:6794¼ 0:9598
C3¼ S½ o¼ go mo ¼ 0:341  1:8¼ 0:6138
where gi; go are intra/extracellular activity coefficients, mi is the calcium concentration in
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junctional subspace, and mo is extracellular calcium concentration. Therefore, C2 > C3 and the
sign of driving force (and thus also ICaL) is positive.
Appendix 1—figure 3. Goldman-Hodgkin-Katz equation with colour coding of components.
However, if we use ionic activity coefficients based on ToR-ORd (0.6532 and 0.6117 for
intracellular/extracellular), we get:
C2¼ gi mi  e
zV F
RT ¼ 0:6532  0:0822  11:6794¼ 0:6269
C3¼ go mo ¼ 0:6117  1:8¼ 1:1011
Therefore, in this case, C2 < C3, and the sign of driving force and ICaL is negative and thus
consistently inward during the AP.
7. P2/P1 protocol for ICaL
We compared the results of the ToR-ORd and ORd models to experimental data in human
myocytes for the P2/P1 protocol reported by Fülöp et al. (2004) as previously shown in the
original ORd model study (O’Hara et al., 2011). In this protocol, two rectangular pulses (from
 40 mV to 10 mV, lasting either 25 ms or 100 ms) are applied, and the ratio of peak ICaL
during the second pulse versus the first one is computed. Simulated curves with both models
are consistent with the data in that a) 25 ms pulse curve lies above the 100 ms pulse curve, b)
shorter coupling interval is associated with less current availability (Appendix 1—figure 4).
Both models show an offset to the experimental data. This could be due to a) Difference in
ICaL behaviour/density and/or calcium loading (affecting inactivation) between the Fülöp (P2/
P1 protocol) and Magyar (the main basis for the ICaL model) studies. It could be also linked to
mechanisms of ICaL inactivation not represented in the model (e.g. the inactivation by the
calcium flow through the channel, represented for example by Mahajan et al., 2008).
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Appendix 1—figure 4. P2/P1 protocol for two pulse durations.
8. Calcium transient amplitude in ToR-ORd
The calcium transient amplitude of 312 nM in baseline ToR-ORd is slightly below the
mean ± std range of 350 (330-370) nM in Coppini et al. (2013). However, we hypothesised
that the difference might be due to the different APD, which affects the calcium loading of the
cell by modulating ICaL duration. When the APD of the ToR-ORd was extended to 351.5 ms
(close to ca. 350 ms reported by Coppini et al.) by reducing IKr by 45%, the calcium transient
amplitude increased to 360 nM, which is close to the data mean. After such an AP
prolongation, both time to peak (54 ms) and calcium transient duration at 90% recovery (459
ms) remained within standard deviation of the data.
9. Summary of literature on sodium blockers, INa, and INaL
reduction
The exact ratio of pharmacological block of INa and INaL is drug and dose-dependent, with late
sodium current generally being blocked somewhat more than the fast sodium current. For
flecainide applied to wild-type Nav1.5, the IC50 value of INa and INaL were 127 ± 6 and 44 ± 2
mM, respectively; for example, for 50% INa block, a 75% INaL block would be expected
(Nagatomo et al., 2000). In the case of TTX, the IC50 values appear to be more similar for the
two currents: 1.2 mM for INa (Bradley et al., 2013) and 0.95 mM for INaL (Horvath et al., 2013).
Lidocaine also appears to block INaL preferentially: the measured IC50 for INaL is 10.79 mM
(Crumb et al., 2016), which is lower than 44 mM measured for INa (Janssen Pharmaceutical
internal database, referred to in Passini et al., 2017). However, we note that comparing IC50
values between studies has limited quantitative relevance, given expected differences
between conditions and protocols.
10. Role of ICaL properties and AP morphology in calcium
transient changes by sodium blockade
The changes in AP morphology and ICaL introduced in the ToR-ORd model improved its
response to Na currents block, particularly with respect to reduction of the Ca transient
amplitude (illustrated in Figure 3). To further dissect the contribution of differences between
ToR-ORd and ORd in AP morphology and ICaL properties, we simulated two AP clamp
scenarios using the four different models considered previously in Appendix 1—figure 2 (i.e.
ORd, ORd and ToR-ORd activity coefficients, ORd and ToR-ORd ICaL activation curve, and
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ToR-ORd). The first scenario applied an AP clamp based on ORd AP morphologies for control
and for 50/50% INa/INaL block (as shown in Figure 3B). The second scenario considered AP
clamps based on ToR-ORd AP morphologies in control and 50/50% INa/INaL block (as shown in
Figure 3A). For each of the four models and the two AP clamp scenarios, the ratio of calcium
transient amplitudes (sodium-block versus control) was computed (Appendix 1—table 1). This
allowed quantifying the importance of differences in AP morphology and updates to the ICaL
representation with regard to CaT amplitude changes under sodium block.
Appendix 1—table 1. Dissection of improvement in reaction to sodium blockade. Ratios of
calcium transient amplitudes for AP clamps corresponding to baseline and sodium-blocked
models, arising from ORd and ToR-ORd. Row/column numbering used in the text does not
include the header and the first column which describes the models (i.e. the text refers to four
rows and two numerical columns).
Model ORd AP clamps ToR-ORd AP clamps
M1 (ORd) 1.366 1.061
M2 (ORd with ToR-ORd activity coefficients) 1.301 0.999
M3 (ORd with ToR-ORd activation curve) 1.326 1.015
M4 (ToR-ORd) 1.193 0.985
A value below one in Appendix 1—table 1 indicates the expected decrease in calcium
transient amplitude with sodium block compared to control. This was achieved only by using
the ToR-ORd AP clamp with the ToR-ORd model (row 4, column 2), and also but to a lesser
extent with the ToR-ORd AP clamp and the ORd with ToR-ORd activity coefficients (row 2,
column 2). Considering the ToR-ORd AP morphology (versus ICaL activation coefficients or
activation curves) has the strongest effect in changes in calcium transient amplitude with
sodium blockade. This is demonstrated by the universally lower values in the second column
of Appendix 1—table 1 compared to the first column. The update of ionic activity
coefficients alone leads to a reduced increase in CaT amplitude (in ORd), or a reduction in
CaT amplitude (in ToR-ORd) following sodium blockade (Appendix 1—table 1, row 2 versus
1). Updated activation curve leads to a less pronounced increase in calcium transient
amplitude in both models (Appendix 1—table 1, row 3 versus 1). Using the fully updated
ToR-ORd model for simulations gave the most pronounced reduction in how much the
calcium transient is increased upon sodium blockade using ORd AP clamps (Appendix 1—
table 1, row 4 versus 1; column 1). It also yielded the most pronounced reduction in calcium
transient amplitude following sodium blockade when using ToR-ORd AP clamps
(Appendix 1—table 1, row 4 versus 1; column 2).
AP morphology and peak AP levels regulate calcium transient amplitude through ICaL, and
specifically through its voltage-dependency of activation curve, driving force and inactivation.
It is important to note key differences between ToR-ORd and ORd models in this respect. In
the ToR-ORd model, the AP morphology and the ICaL activation curve (Figure 2C) mean that
INa blockade leads to a reduction of peak ICaL activation. Conversely, in ORd, the activation
curve is flat from 15 mV on (Figure 2C), and activation is not affected when sodium block
reduces peak and early-plateau potential from 40 mV to 30–35 mV. At the same time,
lowered peak and early-plateau potentials following sodium blockade increase ICaL driving
force and weaken the voltage-driven inactivation, enhancing total ICaL. Furthermore, in the
ToR-ORd model, AP with and without sodium block reach a near-identical notch and early-
plateau potential soon after the peak (Figure 3A). However, in the ORd, the difference in
early-plateau membrane potentials lasts almost 30 ms after the peak (Figure 3B), prolonging
the effect of increased driving force and reduced inactivation on ICaL, which is furthermore
not compensated by reduction in activation.
To further explore the impact of AP morphology on ICaL properties, ICaL activation and
driving force was computed with the ToR-ORd model, again under four AP clamps
considering AP morphologies shown in Figure 3A,B (obtained with ToR-ORd control and 50/
50% INa/INaL block, and ORd control and 50/50% INa/INaL block). The results are presented in
Appendix 1—figure 5. The activation with ToR-ORd AP clamp is reduced with sodium block
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versus control AP clamp morphologies (Appendix 1—figure 5A, yellow vs purple), given the
difference in peak membrane potentials (Figure 3A) and their position on the activation
curve (Figure 2C). However, the activation over time is similar with ORd AP morphology in
control versus sodium block (Appendix 1—figure 5A, red vs blue), as the membrane
potential is so high that full activation is reached in both cases.
Appendix 1—figure 5. Effect of AP morphology on ICaL variables under sodium blockade. (A)
ICaL activation. (B) ICaL driving force. In (C) are shown ratios of curves from (B) red pointwise-
divided by blue (shown in light blue) and purple pointwise-divided by yellow (shown in
green).
Furthermore, the ICaL driving force obtained with the four AP clamps is shown in
Appendix 1—figure 5B (more negative values correspond to a greater driving force), and
Appendix 1—figure 5C displays the ratio of the driving forces between sodium-blocked AP
clamp and control AP clamp for ORd and ToR-ORd morphologies. It is clear that the driving
force elevation under sodium-block AP morphology versus control is much smaller and
shorter lasting when clamping to ToR-ORd than ORd AP morphologies (Appendix 1—figure
5C).
Therefore, the combination of ToR-ORd AP morphology and ICaL activation curve (which is
consistent with experiments and with lower peak and early plateau voltages compared to
ORd) result in reduction in both activation and driving force of ICaL with sodium bock. This
explains how INa block causes a smaller increase in ICaL and thus also in calcium transient
amplitude using the ToR-ORd versus ORd models (Figure 3E and F). This smaller calcium
increase due to INa block is further compensated by the reduction in calcium entry and
loading caused by INaL block. The effect of INaL on the simulated cell’s calcium loading is
mediated by the NCX (reduced sodium influx via INaL reduces calcium influx via NCX) and by
ICaL (APD shortening induced by INaL reduction also shortens ICaL, reducing calcium influx).
Given that the effect of fixed-amount INaL reduction on APD is stronger in ToR-ORd
compared to ORd (Figure 3A,B), INaL loss reduces calcium transient amplitude more in ToR-
ORd.
11. Sodium block in fibre
In order to assess how cell coupling affects the sodium block behaviour, we simulated half-
blocks of INa and INaL in fibre (Appendix 1—figure 6). The effect of the respective blocks is
generally consistent with single-cell behaviour (Figure 3) in that INa block increases calcium
transient amplitude, and INaL block reduces it. The effect of both half-blocks combined shows
the same trend as the single-cell but is of greater magnitude: ToR-ORd shows a greater
reduction in the calcium transient amplitude, while ORd shows a greater increase. In this
section, a version of ORd with updated INa to allow for good propagation was used
(Passini et al., 2016), and the tissue conductivity was set to achieve the conduction velocity
of 63 m/s.
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Appendix 1—figure 6. Effect of sodium blockers on ToR-ORd and ORd in fibre. Membrane
potential in fibre at four simulated conditions (control, half block of fast sodium, half block of
late sodium, and half block of both fast and late sodium currents) in ToR-ORd (A) and ORd
(B). In (C, D) is given the corresponding calcium transient. The measurements were taken in
the node at the half of the fibre; consequently, action potentials in the conditions including
INa block are delayed to the other traces, given corresponding conduction delay.
12. Calibration: ICaL block and IKr replacement
During the model development (with the original ORd formulation of IKr being used at the
stage), we observed that in models with good AP morphology and response to sodium
block, 50% ICaL block resulted in APD prolongation, which is in conflict with experimental
evidence. Dissecting the cause of this phenomenon, we noticed considerably diminished IKr
density upon such treatment. Given that IKr is the dominant repolarising current in human
ventricle and human-specific computer models, this led to a net APD prolongation. The
diminished IKr density is due to the lack of activation of IKr following from the combination of
data-like AP morphology and formulation of fast and slow time constant of activation (Figure
3A in O’Hara et al., 2011). These time constants indicate a rapid activation between 25 and
40 mV, but when the membrane potential is reduced below 15 mV, activation time increases
steeply (both fast and slow time constant are >1000 ms at 0 mV). Therefore, when the 50%
ICaL block reduces plateau potential (a reduction of ca. 10 mV from control data-driven values
of ca. 20 mV at 10 ms, 10 mV at 100 ms), IKr activation is slowed greatly, producing a
reduction in current density.
Subsequently, we sought to understand why this problem was not present in the original
ORd model, which was shown to respond well to ICaL block with regard to APD
(O’Hara et al., 2011; Dutta et al., 2017a). This follows from the high-plateau AP
configuration of ORd (ca. 38 mV at 10 ms and 20 mV at 100 ms); when such a high plateau is
lowered by 10 mV, it still falls within the zone of rapid IKr activation. Under such conditions,
the loss of ICaL shortens the APD much more than the minor loss of IKr prolongs it, with the
net effect being APD shortening.
Importantly, the article describing the Lu-Vandenberg model of IKr (Lu et al., 2001) used
in the final version of ToR- ORd also provides IKr measurements under AP clamp. The study
utilises AP clamps of both normal-plateau ventricular AP and low-plateau Purkinje AP (which
can be taken as a proxy for ICaL blocked ventricular cell). The experimentally measured peak
IKr is slightly reduced in low-plateau AP clamp versus the high-plateau one (reduction to
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70%). This is generally captured by simulations using our version of the Lu-Vandenberg
model (reduction to 57%, Appendix 1—figure 7). However, peak IKr in ORd reduces to mere
15% in the low-plateau AP clamp versus high-plateau one (Appendix 1—figure 7), which is
due to the slow time constant of activation as described above. The fact that IKr is capable of
rapid activation (or recovery from inactivation, mimicking activation) is independently
corroborated also by the elegant study of sinusoidal voltage pulse protocols by
Beattie et al. (2018), where IKr responds noticeably to membrane potential changes around
0 mV.
Appendix 1—figure 7. AP clamps and resulting IKr. (A,B) Endocardial and Purkinje AP used as
an AP clamp (5th beat of the simulation shown). (C) IKr produced by the endocardial AP. (D)
IKr produced by the Purkinje AP. Shown are data manually extracted from Lu et al. (2001), as
well as simulations using ORd and ToR-ORd (L-V, coding for Lu-Vandenberg hERG model). A
normalisation was performed in (C), (D) to facilitate the relative loss of IKr using the low-
plateau AP shape. In (C), the three traces were normalised to 0–1 range via division by
maxima of the traces: maxData, maxORd, maxLV. Subsequently, in (D), the data trace was
divided by maxData, ORd simulation by maxORd, and the ToR-ORd model simulation by
maxLV. Thus, both traces produced by a given model (or measured experimentally) are
divided by the same number, allowing the assessment of relative reduction of IKr at the low-
plateau AP.
13. Validation: drug block and APD
In addition to four drugs and their effect on APD reported in the main
manuscript Dutta et al. (2017b), also studied the effect of BaCl2, modelled as a 90% IK1
block. However, we excluded considering this drug fundamentally due to the uncertainty on
its multichannel effects on several potassium currents, in addition to IK1. Specifically, it was
previously shown that BaCl2 also blocks IKr and IKs at the used concentration
(Weerapura et al., 2004; Gibor et al., 2004). Furthermore, as shown in Kristóf et al.
(2012), even a lower dose of BaCl2 prolongs the AP plateau and early phase of
repolarization, thus at membrane potentials at which IK1 is not activated. This corroborates
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that BaCl2 is likely to block IKr and IKs, in addition to IK1, but to an uncertain degree.
Furthermore, pure block of IK1 in the ORd model results in APD prolongation from around
 50 mV only, which indicates a clear discrepancy with the experimental data.
To further explore this issue, we simulated the effect of pure 90% IK1 block (which is
consistent with the concentration of BaCl2 used in the experiments) as well as additional IKr
block using the ToR-ORd. The results are shown in Appendix 1—table 2.
Appendix 1—table 2. Effect of BaCl2 on APD90 in experiments and simulations using the




(O’Hara et al., 2011)
Simulated
90% IK1 block
Simulated 90% IK1 +
15% IKr block
Simulated 90% IK1 +
30% IKr block
500 ms 271 (50) ms 250 ms 271 ms 297 ms
1000 ms 306 (50) ms 281 ms 307 ms 341 ms
2000 ms 361 (50) ms 286 ms 311 ms 342 ms
For the three basic cycle length tested, the simulations are in overall agreement with the
experimental data (O’Hara et al., 2011), with an improved match for 90% IK1 + 15% IKr
block. It is however uncertain (albeit likely) whether the block of other currents, such as for
example IKs contributes to explain the effect of BaCl2 on the APD.
A second matter discussed in this section is whether the assessment of nisoldipine in
Figure 5D classifies as a calibration or validation result. With respect to ICaL block, the
genetic algorithm optimisation contained a criterion promoting APD shortening in response
to a 50% calcium blockade; however, the degree of block was different (90% when assessing
nisoldipine), and the optimiser did not aim specifically for the APD reported by Dutta et al.
(2017a). Additionally, the IKr formulation substitution was motivated by the poor
performance of the original IKr model in response to 50% ICaL blockade. After the
substitution was performed and the IKr conductance scaled to achieve similar APD at 1 Hz
pacing at control conditions, no further optimization towards the experimental data in
Figure 5D was carried out. Specifically, at no time during development was the model
adjusted to provide predictions close to Dutta et al. (2017a) in reaction to 90% ICaL.
Therefore, APD shortening with ICaL blockade could be considered a partially calibration
criterion, but quantitatively a validation one.
14. Validation: propagation at extreme hyperkalemia
For extracellular potassium higher than 9 mM, a fibre was too inexcitable to support the
propagation of a full AP. However, a partial activation was observed to propagate
throughout the fibre, reaching ca.  30 mV and lasting ca. 50 ms (Appendix 1—figure 8). In
case of localised hyperkalemia, such as during acute myocardial infarction, it is possible that
even such low-peak wave might reactivate nonischemic cells upon exit of the ischemic zone,
triggering re-entry and arrhythmia.
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Appendix 1—figure 8. Subthreshold fibre activation under extreme hyperkalemia. This trace
was measured at the centre of the simulated fibre.
15.Simulation methods
15.1 Simulation details
Cells were stimulated using a conservative potassium stimulus of  53 mV for 1 ms. Fixed
concentrations in the model are: Ko = 5 mM (extracellular potassium), Nao = 140 mM
(extracellular sodium), Cao = 1.8 mM (extracellular calcium), Clo = 150 mM (extracellular
chloride), Cli = 24 mM (intracellular chloride).
15.1.1 Single-cell simulation protocols
All results are shown at the end of a 1000-beat long pre-pacing train of stimuli. Fixed ionic
concentrations were as stated above with two exceptions, where we matched concentrations
to the respective studies (this was done both for ToR-ORd and ORd models when generating
respective figures). The first exception is the replication of the IV relationship and steady-
state inactivation of ICaL, based on Magyar et al. (2000), where Nao = 140.7 mM, Ko = 5.4
mM, Clo = 146.2, and Cao = 2.5. Particularly, the calcium concentration is of importance,
given that it affects the driving force of calcium and thus the IV relationship directly. In
addition to the changed values of extracellular concentrations, we fixated the intracellular
concentrations of sodium (to 0 mM), potassium (to 153 mM), and chloride (to 130 mM) to
match concentrations in the patch-clamp pipette, given that in the long-term, diffusion would
distribute the ions in approximately such way. We decided not to fix calcium levels in the
model to the pipette concentrations (which was calcium-free), given that calcium entry via
ICaL and the resulting release from the SR might last throughout the inactivating pulse,
affecting ICaL function in a persistent way.
A second exception is the protocol of induction of early afterdepolarisations (EADs) based
on Guo et al. (2011). In this case, Nao = 137, Clo = 148, and Cao = 2.
Third, for the P2/P1 protocol (Appendix 1-7), the concentrations were used as in
Fülöp et al. (2004): Cli = 130 mM, Clo = 157 mM, Nao = 144 mM, Cao = 2.5 mM, Ko = 5.6
mM, Ki = 153 mM, Nai = 0 mM.
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15.1.2 Hypertrophic cardiomyopathy and hyperkalemia
representation
15.1.2.1 Hypertrophic cardiomyopathy
Most of ionic remodelling was based on a comprehensive study by Coppini et al.
(2013). All remodelling of HCM cells versus healthy cells was preferentially based on
current density, protein expression if current density was not available, or mRNA
expression if neither of the previous two measurements was available. The degree of
remodelling was based on data means in the Coppini et al. study; where two subunits of
a complex underlying a current were altered, an average of the two values
corresponding to increase/reduction was used. Based on current density, INaL was
increased by 165%, ICaL by 25%, and Ito was reduced by 80%. In addition, consistent
with the study, the time constant of fast inactivation (both voltage and calcium-driven)
was increased by 35%, and the time constant of slow inactivation was increased by 20%.
Based on protein expression, NCX was increased by 50%, Jup was reduced by 35%, and
Jrel by 30%. Based on mRNA, IK1 was reduced by 30%, IKr by 35%, and IKs by 55%. In
addition, INaK was reduced by 30% (Passini et al., 2016), and calcium affinity of troponin
was increased slightly by reducing the Ktrp by 7% (Robinson et al., 2007).
15.1.2.2 Hyperkalemia
Extracellular potassium level was raised from 5 mM with an increment of 0.5 mM up to 10
mM. Effective refractory period was determined using S1-S2 protocol, recording the highest
S2 coupling interval duration which did not lead to propagation. Hyperkalemic conditions
were simulated in a fibre, see below.
15.1.3 Fibre simulation
The 1D fibre tissue simulations (hyperkalemia and Appendix 1-11) were conducted using the
open-source software CHASTE. The homogeneous 1D tissue fibres had a length of 4 cm
consisting of 200 nodes, with a conductivity of 1.64 mS/cm to achieve a diffusion coefficient
of 1.171 cm2/s (Bueno-Orovio et al., 2008). All the fibres were paced for 20 beats before
analysis. For the purpose of measurement of APD or effective refractory period, a stimulus
was considered ‘propagating’ if the peak of membrane potential at the half-point of the fibre
was above 0. Stimuli which did not propagate did not have their APD or refractory period
measured.
15.1.4 Populations of models and drug safety assessment
To assess the performance of the newly developed model for studies of populations of
models, we constructed two populations of models using the ToR-ORd model as
baseline, and the experimentally-calibrated population of models methodology
(Britton et al., 2013; Muszkiewicz et al., 2016; Passini et al., 2017). A total of nine
ionic conductances were randomly varied: fast and late Na+ current (GNa and GNaL
respectively), transient outward K+ current (Gto), rapid and slow delayed rectifier K
+
current (GKr and GKs), inward rectified K
+ current (GK1), Na
+-Ca2+ exchanger (GNCX),
Na+-K+ pump (GNaK) and the L-type Ca2
+ current (PCa). Two variability ranges were
considered: [50-150]% and [0–200]% with respect to the baseline values, consistent with
the reference study (Passini et al., 2017). The number of models passing calibration to
experimental biomarkers was 2666 out of 3000 models generated for the [50-150]%
population, and 817 out of 3000 for the [0–200]% population.
To assess the suitability of the newly developed model for prediction of drug-induced
pro-arrhythmic risk, we also replicated the results of our previous study on human in silico
drug trials in population of human models (Passini et al., 2017), by testing the same 62
reference compounds at multiple concentrations on the [0–200%] population of models
described above. Results were compared in terms of occurrence of drug-induced
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repolarisation abnormalities (RA) in the population and TdP score. CredibleMeds
(Woosley and Romero, 2015) was used as gold standard for TdP risk, dividing the reference
compounds in four categories: 1, high risk; 2, possible risk; 3, conditional risk; 4, safe (when
not included in CredibleMeds).
All the population of models described above were constructed using the Virtual Assay
software (v3.2.1119, 2019 Oxford University Innovation) (Passini et al., 2017). Further
analysis of the results was performed in Matlab (Mathworks Inc Natwick, MA).
15.1.5 Transmurality, 3D simulation, and pseudo-ECG
measurement
The formulation of transmurality (representation of endocardial, midmyocardial, and
epicardial cells) was retained as in O’Hara et al. (2011), with two exceptions. First, the
increase of ICaL conductance from endocardium to midmyocardium was reduced to 2-fold,
which corresponds to the mean of the data (O’Hara et al., 2011, Figure 10). Second, the
increase of Ito from endocardium to both midmyocardium and epicardium was reduced to 2-
fold to avoid excessive notch following the peak of the AP. Membrane potential traces of the
three cell types at 1 Hz pacing are given in Appendix 1—figure 9.
Appendix 1—figure 9. Action potential morphology for three cell subtypes at 1 Hz pacing.
The propagation of the electrical activity in the human ventricles was modelled using the
heart bidomain equations and solved with the Chaste software (Pitt-Francis et al., 2009). A
cardiac magnetic resonance (CMR)-informed torso ventricular model was used. The
ventricular element size was set to 0.4 mm to ensure numerical convergence of the finite
element software Chaste for electrophysiological simulations (Dutta et al., 2016; Pitt-
Francis et al., 2009).
The presented ToR-ORd model was used to represent the membrane kinetics. Transmural
and apex to base cell electrophysiological heterogeneities based on experimental and
clinical data from Okada et al. (2011); Drouin et al. (1995); Taggart (2001); Boukens et al.
(2015) were incorporated in the biventricular heart model. Transmural heterogeneities were
modelled using three layers as in Lyon et al. (2018) of endocardial (45% of the transmural
width), mid-myocardial (25%) and epicardial cells (30%) with different AP properties as shown
above. Apex-to-base heterogeneities were modelled by including a gradual increase of IKs
conductance from base to apex resulting in APD differences of 25 ms.
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Heart fibre directions were generated using the Streeter rule-based method
(Streeter et al., 1969), and tissue conductivities were set to generate realistic conduction
velocities for the ToR-ORd cell model, numerical scheme, and mesh resolution. The
longitudinal intracellular conductivity of 1.64 mS/cm in a 1D fibre model resulted in a
physiological conduction velocity of ~65 cm/s (Taggart et al., 2000). As Cardone-
Noott et al., 2016 used 1.5 mS/cm, intracellular orthotropic conductivities and the
axisymmetric extracellular conductivities were obtained by using a scaling factor of 1.0934 to
the ones in Cardone-Noott et al., 2016.
Sinus rhythm was simulated at 1 Hz using a phenomenological activation model with early
endocardial activation sites and a fast endocardial layer representing a tightly-packed
endocardial Purkinje network (Cardone-Noott et al., 2016) and adapted to the ventricular
geometry (Mincholé et al., 2019).
Simulation of the pseudo-ECG was computed by calculating the extracellular potentials in
the virtual standard 12-lead electrode positions (Lyon et al., 2018) from the ventricular
geometry following the dipole model (Gima and Rudy, 2002) as:










are the electrode position coordinates, D is the diffusion tensor, and
Vm is the membrane potential. The integral is calculated over the whole myocardium
volume, W.
15.1.6 Timely killing of crashing simulations during multiobjective
GA
We found it crucial to modify the behaviour of @ode15s in our simulations, using Matlab
ODE Events to limit 1 s of simulated time to 5 s of runtime (with the runtime being <0.5 s in
normal conditions), killing a simulation upon exceeding the limit. When parameters of the
models are randomly perturbed during GA fitting, it is possible to achieve a combination
which leads to model instability and eventual crash. However, as ode15s attempts to reduce
time step in such a case, it takes up to 6 hr to crash, blocking CPU cores and stalling the
whole generation. With the timely killing of unstable simulations, we could run 30
generations with population size of 2500 in ca. 30 hr on an Azure virtual machine with 64
cores, using parallel fitness evaluation.
15.2 Evaluation pipeline and HTML reporter
In addition to the model code itself, we also provide a model evaluation pipeline. This allows
simulation of the single-cell calibration and validation criteria using a standard model
function (I.e. all except ICaL properties such as I-V relationship, or disease models, where
modified model codes are used.). After the simulation of a comprehensive set of protocols,
an HTML report is produced (Appendix 1—figure 10), providing a clickable mapping
between criteria and figures showing how the model fulfils them. Icons adjacent to the
criteria allow rapid assessment of whether the model behaves well in the given criterion. Any
model with appropriate interface of inputs and outputs can be simulated. It is particularly
easy to simulate variants of the ToR-ORd model, for example with changed conductances of
currents, as the same structure of parameters that is passed to the model simulation wrapper
can be passed to this evaluation pipeline. Given that the evaluation code and subsequent
report generation are fully automated, it is easy to extend the pipeline to compute and
visualise other evaluation criteria.
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Appendix 1—figure 10. Evaluation pipeline. The left menu shows a list of evaluation criteria
with the adjacent icon indicating whether they are fulfilled by the model. The right pane
contains figures visualising the model performance in the criteria. The figures can be either
viewed by scrolling or by clicking the corresponding entry in the left menu. The report
header contains a timestamp of the report generation and a slider which controls the size of
figures in the right pane. The whole report is written in HTML, as automatically generated
from Matlab code, and can be viewed in any internet browser.
The whole process of report generation (and storage of included plots) can be run
separately for calibration and validation criteria (with separately stored figures), facilitating
unbiased model development, where the model can be assessed using the calibration
criteria only, without the user observing any validation results. It is nevertheless possible to
also generate a report for only validation criteria, or both calibration and validation.
Below are given the criteria evaluated, along with how the rating of the model is defined
(PASS = good behaviour in a given criterion, FAIL = problematic behaviour, NA = feature
not automatically compared to data, usually because of difficulty of accurate rating; this code
is also used when a plot is only an illustration, such as examples of action potential shape at
different pacing frequencies). Unless specified otherwise, FAIL is given when PASS is not
fulfilled.
15.2.1 Calibration criteria
1. Action potential morphology. PASS ~ AP from 10 to 500 ms is within the 10–90% quantile
range of the Szeged dataset. The first 10 ms are ignored so as not to limit the model in its
peak potential, as this is strongly modulated by cell coupling (the available AP data are
based on small-tissue samples).
2. Sample traces showing the AP and calcium transient at different pacing frequencies. Always
NA, this is just an illustrator figures useful for an eyeballing-type of assessment.
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3. Calcium transient properties (time to peak, duration at 90% recovery. PASS ~ both features
are within estimated standard deviation of data given in Coppini et al. (2013).
4. Negative inotropy of 50% INa + 50% INaL block. PASS if such treatment induces a reduction
in transient amplitude.
5. APD shortening with 50% ICaL block. PASS if such treatment induces APD shortening.
6. The effect of 50% IK1 block on membrane potential. PASS if such treatment induces
depolarisation.
7. EAD formation. PASS if dV/dt exceeds 0.05 after 50 ms of the AP. This is assessed at 4000
ms bcl, 85% IKr block, and concentrations as given in section 1.3.1.
8. Alternans formation. PASS if alternans of amplitude more than 5 ms is formed at any fre-
quency faster than 300 ms base cycle length. The plots generated can be also used to
assess dynamic restitution of APD.
Conduction velocity is not assessed, as it requires simulating a fibre using other tools than
Matlab.
15.2.2 Validation criteria
1. Four simulated drug blocks from Dutta et al. (2017a):
 E-4031 (IKr blocker)
 HMR-1556 (IKs blocker)
 Mexiletine (INaL, IKr, ICaL blocker)
 Nisoldipine (ICaL blocker)
2. Each is simulated separately, and each is scored as PASS if the model prediction is within
the standard deviation of the data.
3. APD accommodation. Always NA, as it is challenging how to define agreement with data
exactly.
4. S1-S2 protocol. Always NA, just a comparison to data is given.
Effects of hyperkalemia, POM and drug safety testing, or 3D heart simulation are not
assessed automatically, as they requires simulation tools other than Matlab.
15.3 Summary of updated equations
Below are the equations which have been added and/or changed in the ORd model. The
equations follow the naming convention of the ORd model with the exception of INa, I(Ca)Cl,
IClb, and IK1, which are based on different models. Membrane potential is expressed as V .
15.3.1 INa
The Grandi et al. (2010) model of INa was used as a baseline, which was extended to
account for the effect of CaMKII via modulation of the h gate (a shift by 6 mV) and the 1.46
times increase of the time constant of j (recovery from inactivation), consistent with
(O’Hara et al., 2011). The current was included within the membrane adjacent to the main
cytosolic pool as in ORd. The equations underlying describing the Grandi model were






t m ¼ 0:1292  e 
Vþ45:79
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ah ¼ 0:057  e
  Vþ80
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1þe 0:1 Vþ32ð Þ otherwise
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INa ¼GNa m3  1  fINap
  
 h  jþ fINap  hp  jp
  
where hp is the phosphorylated h gate, jp is the phosphorylated j gate, and fINap is the
fraction of CaMKII-phosphorylated sodium channels.
15.3.2 INaL
As the ORd model assumes the time constant of INaL activation to be the same as the one of
INa, t m of INaL in ToR-ORd was likewise set to t m of the extended Grandi INa model as
described above.
t m;L ¼ 0:1292  e 
Vþ45:79
15:54ð Þ2 þ 0:06487  e  V 4:82351:12ð Þ
2
In addition, the conductance was changed:
GNaL ¼ 0:0279
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15.3.3 ICaL
15.3.3.1 Activation
Steady-state activation was reformulated as the following Gompertz function restricted to
[0,1].
d¥ ¼ 1:0763  e 1:007e
 0:0829V
for V  31:4978 j1 otherwise
 
15.3.3.2 Localisation
20% of ICaL was placed within the membrane adjacent to the main cytosolic ionic pool (ICaL;i);
80% is included within membrane adjacent to the ’subspace’ compartment (ICaL;SS). Total ICaL
(the sodium and potassium currents carried by the channel are treated analogously) is given
as follows:
ICaL ¼ 0:8  ICaL;SS þ 0:2  ICaL;i
The two parts of ICaL differ in the driving force (which differs between subspace and main
ionic pool based on potentially different ionic concentrations), and n, the variable
determining the degree of calcium inactivation. We separated the original n variable into nSS
(fraction of calcium-inactivated ICaL channels in the junctional subspace) and ni (fraction of
calcium-inactivated ICaL channels in the main cytosolic ionic pool). These are updated as n in
the original model, except that ni is updated using the calcium concentration in the main
cytosolic pool, rather than in junctional subspace.
15.3.3.3 Driving force
Driving force is modelled using the Goldman-Hodgkin-Katz equation as in the original
model, but this is computed separately for ICaL adjacent to junctional subspace compartment
and the main cytosolic ionic pool, using corresponding ionic concentrations and activity
coefficients. Activity coefficient gX;SS (activity of ionic specie X, such as Ca, Na, or K in the














where A¼ 1:82  106  74  310ð Þ 1:5, zX is the charge of X, and I is the ionic strength:
I ¼ 0:5 
i
X
ci  z2i ;
where ci is the molarity (I.e. the concentrations used throughout the model, which are given
in mM, are divided by 1000 to convert them to M.) of the i-th ion (ToR-ORd takes into
account calcium, sodium, potassium, and chloride) in the given compartment, and zi is its
charge.
In total, three values of ionic strength are used in ToR-ORd for one ionic specie, one for
each of the following compartments: extracellular, main intracellular pool, and junctional









k¼2;n ¼ 500 used both in computation of ni and nssð Þ
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The Lu-Vandenberg (Lu et al., 2001) model was used, with structure given in Figure 1B of
the main manuscript. The model is used as published, except with slightly increased a1;bi,
and different conductance. In this section, I without a subscript stands for the fraction of




vfrt ¼ V  F
R T
a¼ 0:1161  e0:299vfrt
b¼ 0:2442  e 1:604  vfrt
a1 ¼ 1:25  0:1235
b1 ¼ 0:1911
a2 ¼ 0:0578  e0:971vfrt
b2 ¼ 0:349  10 3  e 1:062  vfrt
ai ¼ 0:2533  e0:5953vfrt
bi ¼ 1:25  0:0522  e 0:8209  vfrt









¼C0 aþC2 b1  C1  bþa1ð Þ
Tomek et al. eLife 2019;8:e48890. DOI: https://doi.org/10.7554/eLife.48890 45 of 48
Research article Cell Biology Computational and Systems Biology
dC2
dt
¼C1 a1 þO b2 þ I bItoC2 C2  b1þa2 þaC2toIð Þ
GKr ¼ 0:0321





O  V  EKð Þ




The formulation below is based on Carro et al. (2011), updated to take into account that
extracellular potassium in our model is 5 mM, rather than 5.4.
aK1 ¼
4:094
1þ e0:1217 V EK 49:934ð Þ
bK1 ¼
15:72  e0:0674 V EK 3:257ð Þþ e0:0618 V EK 594:31ð Þ










K1SS  V  EKð Þ
15.3.8 INaCa
GNCX ¼ 0:0034




This current is placed within the junctional subspace
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I Cað ÞCl ¼









IKb ¼ 0:0189  xKb  V  EKð Þ
15.3.13 ICab
vffrt¼ V F  F
R T
vfrt ¼ V  F
R T
ICab ¼ 5:9194  10 8  4  vffrt 
gCai Cai  e2vfrt  gCao Cao
e2vfrt   1
The second half of the right hand side (from vffrt on, inclusive) is the Goldman-Hodgkin-
Katz driving force; gCai is the activity coefficient of intracellular calcium (in the main ionic
pool), and gCao is the activity coefficient of extracellular calcium.
15.3.14 INab
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Jrel ¼ 1:5378  1  rel;CaMK
  
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